Clinical Trial Update: Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage [Phase 2]

View source ↗

Summary

Insud Pharma is conducting a Phase 2 trial evaluating sublingual oxytocin to prevent postpartum hemorrhage. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Insud Pharma | Conditions: Post Partum Hemorrhage | Phase 2 | Status: NOT_YET_RECRUITING